CYP1B1 Polymorphisms and Susceptibility to Prostate Cancer: A Meta-Analysis

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Zhang, Hongtuan ^a   Li, Liang ^a   Xu, Yong ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1B1;

ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CYP1B1 GENE; DOMINANT INHERITANCE; ETHNICITY; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; PROSTATE CANCER; RECESSIVE INHERITANCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; ARYL HYDROCARBON HYDROXYLASES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DATABASES, BIBLIOGRAPHIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MODELS, STATISTICAL; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84879818817     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068634     Document Type: Article

References (30)

1. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
2. Siegel R, Ward E, Brawley O, Jemal A, (2011) Cancer statistics, 2011. CA Cancer J Clin 61: 212-236.
3. Plummer SJ, Conti DV, Paris PL, Curran AP, Casey G, et al. (2003) CYP3A4 and CYP3A5 genotypes, haplotypes, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 12: 928-932.
4. Cicek MS, Conti DV, Curran A, Neville PJ, Paris PL, et al. (2004) Association of prostate cancer risk and aggressiveness to androgen pathway genes: SRD5A2, CYP17, and the AR. Prostate 59: 69-76.
5. Sutter TR, Tang YM, Hayes CL, Wo YY, Jabs EW, et al. (1994) Complete cDNA sequence of a human dioxin-inducible Mrna identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J Biol Chem 269: 13092-13099.
6. Tang YM, Wo YY, Stewart J, Hawkins AL, Griffin CA, et al. (1996) Isolation and characterization of the human cytochrome P450 CYP1B1 gene. J Biol Chem 271: 28324-28330.
7. Hayes CL, Spink DC, Spink BC, Cao JQ, Walker NJ, et al. (1996) 17-β estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc Natl Acad Sci USA 93: 9776-9781.
8. Bejjani BA, Lewis RA, Tomey KF, Anderson KL, Dueker DK, et al. (1998) Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia. Am J Hum Genet 62: 325-333.
9. Martin FL, Patel II, Sozeri O, Singh PB, Ragavan N, et al. (2010) Constitutive expression of bioactivating enzymes in normal human prostate suggests a capability to activate pro-carcinogens to DNA-damaging metabolites. Prostate 70: 1586-1599.
10. Spink DC, Spink BC, Cao JQ, Gierthy JF, Hayes CL, et al. (1997) Induction of cytochrome P450 1B1 and catechol estrogen metabolism in ACHN human renal adenocarcinoma cells. J Steroid Biochem Mol Biol 62: 223-232.
11. Sissung TM, Danesi R, Price DK, Steinberg SM, de Wit R, et al. (2008) Association of the CYP1B1*3 allele with survival in patients with prostate cancer receiving docetaxel. Mol Cancer Ther 7: 19-26.
12. Hanna IH, Dawling S, Roodi N, Guengerich FP, Parl FF, (2000) Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res 60: 3440-3444.
13. Shimada T, Watanabe J, Kawajiri K, Sutter TR, Guengerich FP, et al. (1999) Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogenesis 20: 1607-1613.
14. Yang J, Xu DL, Lu Q, Han ZJ, Tao J, et al. (2012) Prostate cancer risk and aggressiveness associated with the CYP1B1 4326C/G (Leu432Val) polymorphism: a meta-analysis of 2788 cases and 2968 controls. Asian J Androl14: 560-565.
15. Cui L, Dillehay K, Chen W, Shen D, Dong Z, et al. (2012) Association of the CYP1B1 Leu432Val polymorphism with the risk of prostate cancer: a meta-analysis. Mol Biol Rep 39: 7465-7471.
16. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
17. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
18. Holt SK, Kwon EM, Fu R, Kolb S, Feng Z, et al. (2013) Association of variants in estrogen-related pathway genes with prostate cancer risk. Prostate 73: 1-10.
19. Catsburg C, Joshi AD, Corral R, Lewinger JP, Koo J, et al. (2012) Polymorphisms in carcinogen metabolism enzymes, fish intake, and risk of prostate cancer. Carcinogenesis 33: 1352-1359.
20. Rodrigues IS, Kuasne H, Losi-Guembarovski R, Fuganti PE, Gregório EP, et al. (2011) Evaluation of the influence of polymorphic variants CYP1A1 2B, CYP1B1 2, CYP3A4 1B, GSTM1 0, and GSTT1 0 in prostate cancer. Urol Oncol 29: 654-663.
21. Beuten J, Gelfond JA, Franke JL, Weldon KS, Crandall AC, et al. (2009) Single and multigenic analysis of the association between variants in 12 steroid hormone metabolism genes and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 18: 1869-1880.
22. Beuten J, Gelfond JA, Byrne JJ, Balic I, Crandall AC, et al. (2008) CYP1B1 variants are associated with prostate cancer in non-Hispanic and Hispanic Caucasians. Carcinogenesis 29: 1751-1757.
23. Cussenot O, Azzouzi AR, Nicolaiew N, Fromont G, Mangin P, et al. (2007) Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens. J Clin Oncol 25: 3596-3602.
24. Berndt SI, Chatterjee N, Huang WY, Chanock SJ, Welch R, et al. (2007) Variant in sex hormone-binding globulin gene and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 16: 165-168.
25. Sobti RC, Onsory K, Al-Badran AI, Kaur P, Watanabe M, et al. (2006) CYP17, SRD5A2, CYP1B1, and CYP2D6 gene polymorphisms with prostate cancer risk in North Indian population. DNA Cell Biol 25: 287-294.
26. Cicek MS, Liu X, Casey G, Witte JS, (2005) Role of androgen metabolism genes CYP1B1, PSA/KLK3, and CYP11alpha in prostate cancer risk and aggressiveness. Cancer Epidemiol Biomarkers Prev 14: 2173-2177.
27. Fukatsu T, Hirokawa Y, Araki T, Hioki T, Murata T, et al. (2004) Genetic polymorphisms of hormone-related genes and prostate cancer risk in the Japanese population. Anticancer Res 24: 2431-2437.
28. Chang BL, Zheng SL, Isaacs SD, Turner A, Hawkins GA, et al. (2003) Polymorphisms in the CYP1B1 gene are associated with increased risk of prostate cancer. Br J Cancer 89: 1524-1529.
29. Tanaka Y, Sasaki M, Kaneuchi M, Shiina H, Igawa M, et al. (2002) Polymorphisms of the CYP1B1 gene have higher risk for prostate cancer. Biochem Biophys Res Commun 296: 820-826.
30. Tang YM, Green BL, Chen GF, Thompson PA, Lang NP, et al. (2000) Human CYP1B1 Leu432Val gene polymorphism: ethnic distribution in African-Americans, Caucasians and Chinese; oestradiol hydroxylase activity; and distribution in prostate cancer cases and controls. Pharmacogenetics 10: 761-766.